The search frequency for Dongwha Pharm, recently known as a manufacturer and seller of pharmaceuticals such as Gas Hwal Myeong Su and Fusidin, has surged.

As of 12:31 PM on the 9th, Dongwha Pharm's stock price rose 6.82% from the previous day to 16,450 KRW, with a trading volume of 6,963,230 shares, which is about 96.49% of the 5-day average trading volume. Foreign investors are tentatively estimated to have net purchased 30,187 shares today.

On June 5th, Dongwha Pharm became a market issue with an 18% increase, citing "COVID-19 treatment 'animal testing imminent'."



[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


Hot Picks Today

"Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money] "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]

한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing